Pro-Dex (FRA:PDXN) FFO


FRA:PDXN Pro-Dex Inc FRA:PDXN
64 GF Score
Price €52.50
GF Value €36.18
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Pro-Dex FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PDXN
64GF Score
Pro-Dex Inc FRA:PDXN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pro-Dex (FRA:PDXN) Overvalued in 2026?

Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued. The current stock price of €52.50 is trading 45.1% above its estimated GF Value™ of €36.18. GuruFocus considers Pro-Dex to be Significantly Overvalued.

Key valuation signals for FRA:PDXN:

  • FFO:
  • GF Value™: €36.18 vs. price of €52.50 (45.1% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pro-Dex Business Description

Other Exchanges PDEX:USA
Address 2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
64GF Score

Get the complete analysis for FRA:PDXN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€52.50
Price
€36.18
GF Value